Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Media
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
  • e3
  • Concept Fund
  • iMCI
  • Portfolio
  • ACT Tulsa
  • Contact

News

OKC firm seeking to boost effectiveness of antibiotics receives investment

By admin | Entrepreneur, News, SeedStep Angels | Comments are Closed | 4 August, 2015 | 0

From Staff Reports Copyright © 2015 The Oklahoma Publishing Co. i2E Inc. and Accele Venture Partners recently closed a $600,000 follow-on investment in Synereca Pharmaceuticals, a portfolio company of Accele Biopharma, an Oklahoma City-based biotechnology accelerator. With the most recent investment, Synereca has now received $2.5 million in funding to support its development of compoundsRead more

Pamlico Biopharma raises $2.2M

By admin | Entrepreneur, News, SeedStep Angels | Comments are Closed | 3 May, 2015 | 0

i2E and Accele Venture capital recently lead a $2.2 million investment in Pamilco Biopharma. i2E invested t through its Oklahoma Seed Capital Fund.

i2E, Accele close $2.2M Investment in Pamlico

By admin | Entrepreneur, News, SeedStep Angels | Comments are Closed | 30 April, 2015 | 0

i2E, Inc., and Accele Venture Partners recently closed a $2.2 million investment in Pamlico Biopharma, Inc., a portfolio company of Accele Biopharma, an Oklahoma City-based biotechnology accelerator.

i2E leads $1.4M investment in Synereca

By admin | Entrepreneur, News, Publish in TEN, SeedStep Angels | Comments are Closed | 16 September, 2014 | 0

Synereca Pharmaceuticals has received $1.4 million in seed capital from i2E Inc. The Oklahoma City-based company is developing a compound that kills drug resistant bacteria.

i2E leads $1.4M investment in Synereca

By admin | Entrepreneur, News, SeedStep Angels, Uncategorized | Comments are Closed | 9 September, 2014 | 0

i2E, Inc., recently closed on a $1.4 million seed capital investment in Oklahoma City-based Synereca Pharmaceuticals, which is developing ground-breaking compound that kills drug resistant bacteria.

i2E-300dpi-Trans-Light
  • Events
  • News
  • Resources
  • Media
  • Love’s Cup

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
PHONE 405/235-2305
Click HERE for printable map with directions.

Tulsa Office

100 S. Cincinnati Ave – 5th Floor, Suite 514
Tulsa, OK 74103
PHONE 918/582-5592
Copyright 2022 i2E, Inc. | All Rights Reserved
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
    • ACT Tulsa
  • e3
  • Concept Fund
  • Portfolio
  • iMCI
  • ACT Tulsa
  • Contact
i2E